These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25088927)

  • 1. Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetes.
    Chong CR; Chan WP; Nguyen TH; Liu S; Procter NE; Ngo DT; Sverdlov AL; Chirkov YY; Horowitz JD
    Cardiovasc Drugs Ther; 2014 Aug; 28(4):347-60. PubMed ID: 25088927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studies.
    Connelly KA; Advani A; Advani SL; Zhang Y; Kim YM; Shen V; Thai K; Kelly DJ; Gilbert RE
    Acta Diabetol; 2014 Oct; 51(5):771-82. PubMed ID: 24925443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thioredoxin system as a therapeutic target in human health and disease.
    Mahmood DF; Abderrazak A; El Hadri K; Simmet T; Rouis M
    Antioxid Redox Signal; 2013 Oct; 19(11):1266-303. PubMed ID: 23244617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia regulates TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic cancer.
    Li W; Wu Z; Ma Q; Liu J; Xu Q; Han L; Duan W; Lv Y; Wang F; Reindl KM; Wu E
    Curr Cancer Drug Targets; 2014; 14(4):348-56. PubMed ID: 24720336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor activation in a diabetic-like environment: potential role in the activity of the endothelial pro-inflammatory and thioredoxin pathways.
    Zitman-Gal T; Golan E; Green J; Bernheim J; Benchetrit S
    J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):1-7. PubMed ID: 22531461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. trans-Resveratrol downregulates Txnip overexpression occurring during liver ischemia-reperfusion.
    Nivet-Antoine V; Cottart CH; Lemaréchal H; Vamy M; Margaill I; Beaudeux JL; Bonnefont-Rousselot D; Borderie D
    Biochimie; 2010 Dec; 92(12):1766-71. PubMed ID: 20709139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid Upregulates Thioredoxin-interacting Protein in Cultured Neuronal Cells.
    Bharti V; Tan H; Chow D; Wang Y; Nagakannan P; Eftekharpour E; Wang JF
    Neuroscience; 2018 Aug; 384():375-383. PubMed ID: 29894818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrosative/oxidative stress conditions regulate thioredoxin-interacting protein (TXNIP) expression and thioredoxin-1 (TRX-1) nuclear localization.
    Ogata FT; Batista WL; Sartori A; Gesteira TF; Masutani H; Arai RJ; Yodoi J; Stern A; Monteiro HP
    PLoS One; 2013; 8(12):e84588. PubMed ID: 24376827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thioredoxin-interacting protein: a new potential target for diabetes and related vascular complications therapy].
    Wu P; Du GH
    Yao Xue Xue Bao; 2015 Dec; 50(12):1559-64. PubMed ID: 27169277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare sugar D-allose strongly induces thioredoxin-interacting protein and inhibits osteoclast differentiation in Raw264 cells.
    Yamada K; Noguchi C; Kamitori K; Dong Y; Hirata Y; Hossain MA; Tsukamoto I; Tokuda M; Yamaguchi F
    Nutr Res; 2012 Feb; 32(2):116-23. PubMed ID: 22348460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thioredoxin antioxidant system.
    Lu J; Holmgren A
    Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the Functions of Thioredoxin System in Central Nervous System Diseases.
    Jia J; Xu G; Zhu D; Liu H; Zeng X; Li L
    Antioxid Redox Signal; 2023 Feb; 38(4-6):425-441. PubMed ID: 35761787
    [No Abstract]   [Full Text] [Related]  

  • 13. Thioredoxin Interacting Protein Inhibitors in Diabetes Mellitus: A Critical Review.
    Kar A; Paramasivam B; Jayakumar D; Swaroop AK; Jubie S
    Curr Drug Res Rev; 2023; 15(3):228-240. PubMed ID: 36786139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication.
    Nasoohi S; Ismael S; Ishrat T
    Mol Neurobiol; 2018 Oct; 55(10):7900-7920. PubMed ID: 29488135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells.
    Yamawaki H; Pan S; Lee RT; Berk BC
    J Clin Invest; 2005 Mar; 115(3):733-8. PubMed ID: 15696199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms.
    Spindel ON; World C; Berk BC
    Antioxid Redox Signal; 2012 Mar; 16(6):587-96. PubMed ID: 21929372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2.
    Watanabe R; Nakamura H; Masutani H; Yodoi J
    Pharmacol Ther; 2010 Sep; 127(3):261-70. PubMed ID: 20435060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential mechanism of metformin-mediated regulation of glucose homeostasis: inhibition of Thioredoxin-interacting protein (Txnip) gene expression.
    Chai TF; Hong SY; He H; Zheng L; Hagen T; Luo Y; Yu FX
    Cell Signal; 2012 Aug; 24(8):1700-5. PubMed ID: 22561086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thioredoxin and thioredoxin reductase: current research with special reference to human disease.
    Holmgren A; Lu J
    Biochem Biophys Res Commun; 2010 May; 396(1):120-4. PubMed ID: 20494123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein.
    Hwang J; Suh HW; Jeon YH; Hwang E; Nguyen LT; Yeom J; Lee SG; Lee C; Kim KJ; Kang BS; Jeong JO; Oh TK; Choi I; Lee JO; Kim MH
    Nat Commun; 2014; 5():2958. PubMed ID: 24389582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.